Education
About Us
Working with TipRanks
Follow Us
Akari Therapeutics (AKTX)
NASDAQ:AKTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | - | - | - | - |
| Operating Income | $ -21.64M | $ -16.81M | $ -23.09M | $ -17.21M | $ -17.98M |
| EBITDA | $ -21.64M | $ -16.80M | $ -23.08M | $ -17.21M | $ -20.44M |
| Net Income | $ -19.79M | $ -10.01M | $ -6.97M | $ -17.61M | $ -17.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.60M | $ 3.85M | $ 13.25M | $ 9.36M | $ 14.06M |
| Total Assets | $ 50.56M | $ 4.36M | $ 13.83M | $ 11.65M | $ 17.59M |
| Total Debt | $ 3.26M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 661.00K | $ -3.85M | $ -13.25M | $ -9.36M | $ -14.06M |
| Total Liabilities | $ 28.33M | $ 4.58M | $ 12.04M | $ 6.09M | $ 5.22M |
| Stockholders' Equity | $ 22.23M | $ -229.00K | $ 1.79M | $ 5.55M | $ 12.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.55M | $ -16.43M | $ -21.50M | $ -18.85M | $ -16.95M |
| Operating Cash Flow | $ -12.55M | $ -16.43M | $ -21.50M | $ -18.85M | $ -16.95M |
| Investing Cash Flow | $ 382.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 10.99M | $ 7.02M | $ 25.29M | $ 14.29M | $ 25.07M |
Akari Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.